Ketamine abuse potential and use disorder

Brain Research Bulletin

Volumn 126, Issue , 2016, Pages 68-73

  Liu, Yu ^a   Lin, Deyong ^a   Wu, Boliang ^a   Zhou, Wenhua ^a,b  

^a NINGBO UNIVERSITY   (China)

^b Drug Addiction Treatment Centers   (China)

Author keywords

Anti depressant; Ketamine abuse; Neurobiology; Pharmacology; Toxic effect

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; DOPAMINE; KETAMINE; ANTIDEPRESSANT AGENT;

ANTIDEPRESSANT ACTIVITY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG ABUSE; HUMAN; LEARNING; MEMORY; NEUROCHEMISTRY; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; ANIMAL; BRAIN CHEMISTRY; DRUG EFFECTS; REINFORCEMENT; SOCIAL BEHAVIOR; SUBSTANCE-RELATED DISORDERS;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN CHEMISTRY; HUMANS; KETAMINE; REINFORCEMENT (PSYCHOLOGY); SOCIAL BEHAVIOR; SUBSTANCE-RELATED DISORDERS;

EID: 84989199327     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2016.05.016     Document Type: Review

References (117)

1. Administration, S.A.M.H.S, The NSDUH Report Use of Specific Hallucinogens: 2006., 2008, Office of Applied Studies, Rockville, MD.
2. Anticevic, A., Gancsos, M., Murray, J.D., Repovs, G., Driesen, N.R., Ennis, D.J., Niciu, M.J., Morgan, P.T., Surti, T.S., Bloch, M.H., NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia. Proc. Natl. Acad. Sci. USA, 109(41), 2012 16720–5.
3. Bardo, M.T., Bevins, R.A., Conditioned place preference: what does it add to our preclinical understanding of drug reward?. Psychopharmacology (Berl) 153 (2000), 31–43.
4. Bergman, J., Paronis, C.A., Measuring the reinforcing strength of abused drugs. Mol. Interv. 6 (2006), 273–283.
5. Berman, R.M., Cappiello, A., Anand, A., Dan, A.O., Heninger, G.R., Charney, D.S., Krystal, J.H., Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 47 (2000), 351–354.
6. Bokor, G., Anderson, P.D., Ketamine: an update on its abuse. J. Pharm. Pract. 27 (2014), 582–586.
7. Bossert, J.M., Marchant, N.J., Calu, D.J., Shaham, Y., The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research. Psychopharmacology (Berl) 229 (2013), 453–476.
8. Botanas, C.J., Peña, J.B.D.L., Peña, I.J.D., Tampus, R., Yoon, R., Kim, H.J., Yong, S.L., Jang, C.G., Cheong, J.H., Methoxetamine, a ketamine derivative, produced conditioned place preference and was self-administered by rats: evidence of its abuse potential. Pharmacol. Biochem. Behav. 133 (2015), 31–36.
9. Breen, C., Degenhardt, L., White, B., Bruno, R., Chanteloup, F., Fisher, J., Johnston, J., Kinner, S., Moon, C., Proufoot, P., et al. Australian Party Drugs Trends 2003: Findings from the Party Drug Initiative. 2008, National Drug and Alcohol Research Centre, Sydney.
10. Britt, G.C., McCance-Katz, E.F., A brief overview of the clinical pharmacology of club drugs. Subst. Use Misuse 40 (2005), 1189–1201.
11. Broadbear, J.H., Winger, G., Woods, J.H., Self-administration of fentanyl: cocaine and ketamine: effects on the pituitary-adrenal axis in rhesus monkeys. Psychopharmacology (Berl) 176 (2004), 398–406.
12. Cami, J., Farre, M., Drug addiction. N. Engl. J. Med. 349 (2003), 975–986.
13. Chakraborty, K., Neogi, R., Basu, D., Club drugs: review of the ‘rave’ with a note of concern for the Indian scenario. Indian J. Med. Res. 133 (2011), 594–604.
14. Chan, K.W.S., Lee, T.M.C., Siu, A.M.H., Wong, D.P.L., Kam, C.M., Tsang, S.K.M., Chan, C.C.H., Effects of chronic ketamine use on frontal and medial temporal cognition. Addict. Behav. 38 (2013), 2128–2132.
15. Chan, M.H., Chiu, P.H., Lin, C.Y., Chen, H.H., Inhibition of glycogen synthase kinase-3 attenuates psychotomimetic effects of ketamine. Schizophr. Res. 136 (2012), 96–103.
16. Chang, H.C., Chen, T.L., Chen, R.M., Cytoskeleton interruption in human hepatoma HepG2 cells induced by ketamine occurs possibly through suppression of calcium mobilization and mitochondrial function. Drug Metab. Dispos. 37 (2009), 24–31.
17. Chatterjee, M., Ganguly, S., Srivastava, M., Palit, G., Effect of ‘chronic’ versus ‘acute’ ketamine administration and its ‘withdrawal’ effect on behavioural alterations in mice: implications for experimental psychosis. Behav. Brain Res. 216 (2011), 247–254.
18. Chen, W.Y., Huang, M.C., Lin, S.K., Gender differences in subjective discontinuation symptoms associated with ketamine use. Subst. Abuse Treat. Prev. Policy, 9, 2014, 39.
19. Cheng, J.Y., Chan, D.T., Mok, V.K., An epidemiological study on alcohol/drugs related fatal traffic crash cases of deceased drivers in Hong Kong between 1996 and 2000. Forensic Sci. Int. 153 (2005), 196–201.
20. Chu, S.K., Ma, W.K., Wong, C.W., Chu, W.H., Cheng, C.H., Wong, S., Tse, M.L., Lau, F.L., Yiu, M.K., Man, C.W., The destruction of the lower urinary tract by ketamine abuse: a new syndrome. Br. J. Urol. Int. 102 (2008), 1616–1622.
21. Cloke, J.M., Winters, B.D., α 4 β 2 Nicotinic receptor stimulation of the GABAergic system within the orbitofrontal cortex ameliorates the severe crossmodal object recognition impairment in ketamine-treated rats: implications for cognitive dysfunction in schizophrenia. Neuropharmacology 90 (2014), 42–52.
22. Copeland, J., Dillon, P., The health and psycho-social consequences of ketamine use. Int. J. Drug Policy 16 (2005), 122–131.
23. Costi, S., Dam, N.T.V., Murrough, J.W., Current status of ketamine and related therapies for mood and anxiety disorders. Curr. Behav. Neurosci. Rep. 2 (2015), 216–225.
24. Coyle, C.M., Laws, K.R., The use of ketamine as an antidepressant: a systematic review and meta-analysis. Hum. Psychopharmacol. Clin. Exp. 30 (2015), 233–237.
25. Curran, H.V., Morgan, C., Cognitive, dissociative and psychotogenic effects of ketamine on recreational users on the night of drug use and 3 days later. Addiction 95 (2000), 575–590.
26. Dakwar, E., Anerella, C., Hart, C.L., Levin, F.R., Mathew, S.J., Nunes, E.V., Therapeutic infusions of ketamine: do the psychoactive effects matter?. Drug Alcohol Depend. 136 (2014), 153–157.
27. Dakwar, E., Levin, F., Foltin, R.W., Nunes, E.V., Hart, C.L., The effects of subanesthetic ketamine infusions on motivation to quit and cue-induced craving in cocaine-dependent research volunteers. Biol. Psychiatry 76 (2014), 40–46.
28. Daskalopoulou, M., Rodger, A., Thornton, A., Phillips, A., Sherr, L., Gilson, R., Johnson, M., Fisher, M., Anderson, J., McDonnell, J., et al. Sexual behaviour, recreational drug use and hepatitis C co-infection in HIV-diagnosed men who have sex with men in the United Kingdom: results from the ASTRA study. J. Int. AIDS Soc., 17, 2014, 19630.
29. De Luca, M.T., Badiani, A., Ketamine self-administration in the rat: evidence for a critical role of setting. Psychopharmacology (Berl) 214 (2011), 549–556.
30. Deneau, G., Yanagita, T., Seevers, M.H., Self-administration of psychoactive substances by the monkey. Psychopharmacologia 16 (1969), 30–48.
31. Dreizin, R.S., Drug self-administration by laboratory animals: control by schedules of reinforcement. Annu. Rev. Pharmacol. Toxicol. 18 (1978), 313–339.
32. Duan, T.T., Tan, J.W., Yuan, Q., Cao, J., Zhou, Q.X., Xu, L., Acute ketamine induces hippocampal synaptic depression and spatial memory impairment through dopamine D1/D5 receptors. Psychopharmacology (Berl) 228 (2013), 451–461.
33. Farahmandfar, M., Akbarabadi, A., Bakhtazad, A., Zarrindast, M.R., Recovery from ketamine-induced amnesia by blockade of GABA-A receptor in medial prefrontal cortex of mice. Neuroscience, 2016.
34. Gable, R.S., Acute toxic effects of club drugs. J. Psychoactive Drugs 36 (2004), 303–313.
35. Giorgetti, R., Marcotulli, D., Tagliabracci, A., Schifano, F., Effects of ketamine on psychomotor, sensory and cognitive functions relevant for driving ability. Forensic Sci. Int. 252 (2015), 127–142.
36. Guo, R., Tang, Q., Ye, Y., Lu, X., Chen, F., Dai, X., Yan, Y., Liao, L., Effects of gender on ketamine-induced conditioned placed preference and urine metabonomics. Regul. Toxicol. Pharmacol. 77 (2016), 263–274.
37. Hancock, P.J., Stamford, J.A., Stereospecific effects of ketamine on dopamine efflux and uptake in the rat nucleus accumbens. Br. J. Anaesth. 82 (1999), 603–608.
38. Hills, C.E., Jin, T., Siamantouras, E., Liu, I.K., Jefferson, K.P., Squires, P.E., ‘Special k’ and a loss of cell-to-cell adhesion in proximal tubule-derived epithelial cells: modulation of the adherens junction complex by ketamine. PLoS One, 8, 2013, e71819.
39. Honey, G.D., Honey, R.A., O'Loughlin, C., Sharar, S.R., Kumaran, D., Suckling, J., Menon, D.K., Sleator, C., Bullmore, E.T., Fletcher, P.C., Ketamine disrupts frontal and hippocampal contribution to encoding and retrieval of episodic memory: an fMRI study. Cereb. Cortex 15 (2005), 749–759.
40. Honey, R.A., Honey, G.D., O'Loughlin, C., Sharar, S.R., Kumaran, D., Bullmore, E.T., Menon, D.K., Donovan, T., Lupson, V.C., Bisbrown-Chippendale, R., et al. Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: an FMRI study. Neuropsychopharmacology 29 (2004), 1203–1214.
41. Huang, L.K., Wang, J.H., Shen, S.H., Lin, A.T., Chang, C.Y., Evaluation of the extent of ketamine-induced uropathy: the role of CT urography. Postgrad. Med. J. 90 (2014), 185–190.
42. Huang, M.C., Chen, L.Y., Chen, C.K., Lin, S.K., Potential benefit of lamotrigine in managing ketamine use disorder. Med. Hypotheses 87 (2016), 97–100.
43. Huang, X., Huang, K., Zheng, W., Beveridge, T.J.R., Yang, S., Li, X., Li, P., Zhou, W., Liu, Y., The effects of GSK-3β blockade on ketamine self-administration and relapse to drug-seeking behavior in rats. Drug Alcohol Depend. 147 (2015), 257–265.
44. Jansen, K.L.R., Darracot-Cankovic, R., The nonmedical use of ketamine, part two: a review of problem use and dependence. J. Psychoactive Drugs 33 (2001), 151–158.
45. Jia, Z., Liu, Z., Chu, P., McGoogan, J.M., Cong, M., Shi, J., Lu, L., Tracking the evolution of drug abuse in China, 2003–10: a retrospective, self-controlled study. Addiction 110:Suppl. 1 (2015), 4–10.
46. Kalkan, Y., Tomak, Y., Altuner, D., Tumkaya, L., Bostan, H., Yilmaz, A., Unal, D., Kara, A., Turan, A., Hepatic effects of ketamine administration for 2 weeks in rats. Hum. Exp. Toxicol., 2013.
47. Khanegheini, A., Nasehi, M., Zarrindast, M.R., The modulatory effect of CA1 GABAb receptors on ketamine-induced spatial and non-spatial novelty detection deficits with respect to Ca 2+. Neuroscience 305 (2015), 157–168.
48. Krupitsky, E., Burakov, A., Romanova, T., Dunaevsky, I., Strassman, R., Grinenko, A., Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up. J. Subst. Abuse Treat. 23 (2002), 273–283.
49. Krupitsky, E.M., Burakov, A.M., Dunaevsky, I.V., Romanova, T.N., Slavina, T.Y., Grinenko, A.Y., Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence. J. Psychoactive Drugs 39 (2007), 13–19.
50. Krupitsky, E.M., Grinenko, A.Y., Ketamine psychedelic therapy (KPT): a review of the results of ten years of research. J. Psychoactive Drugs 29 (1997), 165–183.
51. Kurdi, M.S., Theerth, K.A., Deva, R.S., Ketamine: current applications in anesthesia, pain, and critical care. Anesth. Essays Res. 8 (2014), 283–290.
52. Lea, T., Prestage, G., Mao, L., Zablotska, I., de Wit, J., Holt, M., Trends in drug use among gay and bisexual men in Sydney Melbourne and Queensland, Australia. Drug Alcohol Rev. 32 (2013), 39–46.
53. Lee, S.T., Wu, T.T., Yu, P.Y., Chen, R.M., Apoptotic insults to human HepG2 cells induced by S-(+)-ketamine occurs through activation of a Bax-mitochondria-caspase protease pathway. Br. J. Anaesth. 102 (2009), 80–89.
54. Li, B., Liu, M.L., Wu, X.P., Jia, J., Cao, J., Wei, Z.W., Wang, Y.J., Effects of ketamine exposure on dopamine concentrations and dopamine type 2 receptor mRNA expression in rat brain tissue. Int. J. Clin. Exp. Med. 8 (2015), 11181–11187.
55. Li, X., Li, S., Zheng, W., Pan, J., Huang, K., Chen, R., Pan, T., Liao, G., Chen, Z., Zhou, D., et al. Environmental enrichment and abstinence attenuate ketamine-induced cardiac and renal toxicity. Sci. Rep., 5, 2015, 11611.
56. Liang, H.J., Lau, C.G., Tang, A., Chan, F., Ungvari, G.S., Tang, W.K., Cognitive impairments in poly-drug ketamine users. Addict. Behav. 38 (2013), 2661–2666.
57. Lindefors, N., Barati, S., O'Connor, W.T., Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex. Brain Res. 759 (1997), 205–212.
58. Littlewood, C.L., Jones, N., O'Neill, M.J., Mitchell, S.N., Tricklebank, M., Williams, S.C.R., Mapping the central effects of ketamine in the rat using pharmacological MRI. Psychopharmacology (Berl) 186 (2006), 64–81.
59. Liu, Y., Le, F.B., Liu, Y., Wang, X., Lu, L., Conditioned place preference induced by licit drugs: establishment, extinction, and reinstatement. Sci. World J. 8 (2008), 1228–1245.
60. Liu, Z., Lian, Z., Zhao, C., Drug use and HIV/AIDS in China. Drug Alcohol Rev. 25 (2006), 173–175.
61. Mason, K., Cottrell AMCorrigan, A.G., Gillatt, D.A., Mitchelmore, A.E., Ketamine-associated lower urinary tract destruction: a new radiological challenge. Clin. Radiol. 65 (2010), 795–800.
62. Mayberg, T.S., Lam, A.M., Matta, B.F., Domino, K.B., Winn, H.R., Ketamine does not increase cerebral blood flow velocity or intracranial pressure during isoflurane/nitrous oxide anesthesia in patients undergoing craniotomy. Anesth. Analg. 81 (1995), 84–89.
63. Moreton, J.E., Meisch, R.A., Stark, L., Thompson, T., Ketamine self-administration by the rhesus monkey. J. Pharmacol. Exp. Ther. 203 (1977), 303–309.
64. Morgan, C.J., Curran, H.V., Independent Scientific Committee on Drugs, Ketamine use: a review. Addiction 107 (2012), 27–38.
65. Morgan, C.J.A., Curran, H.V., Acute and chronic effects of ketamine upon human memory: a review. Psychopharmacology (Berl) 188 (2006), 408–424.
66. Morgan, C.J.A., Muetzelfeldt, L., Curran, H.V., Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. Addiction 105 (2010), 121–133.
67. Muetzelfeldt, L., Kamboj, S.K., Rees, H., Taylor, J., Morgan, C.J., Curran, H.V., Journey through the K-hole: phenomenological aspects of ketamine use. Drug Alcohol Depend. 95 (2008), 219–229.
68. Nakako, T., Murai, T., Ikejiri, M., Ishiyama, T., Taiji, M., Ikeda, K., Effects of a dopamine D1 agonist on ketamine-induced spatial working memory dysfunction in common marmosets. Behav. Brain Res. 249 (2013), 109–115.
69. Northoff, G., Richter, A., Bermpohl, F., Grimm, S., Martin, E., Marcar, V.L., Wahl, C., Hell, D., Boeker, H., NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI. Schizophr. Res. 72 (2005), 235–248.
70. Pappas, M.K., Halkitis, P.N., Sexual risk taking and club drug use across three age cohorts of HIV-positive gay and bisexual men in New York City. AIDS Care 23 (2011), 1410–1416.
71. Pavarin, R.M., Substance use and related problems: a study on the abuse of recreational and not recreational drugs in Northern Italy. Ann. Ist. Super. Sanita 42 (2006), 477–484.
72. Peng, T.R., Lee, M.C., Wu, T.W., Lan, C.C., Suspected ketamine-associated lower urinary tract symptoms. Urol. J. 11 (2014), 1508–1510.
73. Penning, R., Veldstra, J.L., Daamen, A.P., Olivier, B., Verster, J.C., Drugs of abuse, driving and traffic safety. Curr. Drug Abuse Rev. 3 (2010), 23–32.
74. Powers Iii, A.R., Gancsos, M.G., Finn, E.S., Morgan, P.T., Corlett, P.R., Ketamine-induced hallucinations. Psychopathology 48 (2015), 376–385.
75. Price, R.B., Dan, V.I., Murrough, J.W., Chang, L.C., Jurdi, R.K.A., Iqbal, S.Z., Soleimani, L., Charney, D.S., Alexandra, L.F.M.S., Mathew, S.J., Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression. Depress. Anxiety 31 (2014), 335–343.
76. Reynaud-Maurupt, C., Bello, P.Y., Akoka, S., Toufik, A., Characteristics and behaviors of ketamine users in France in 2003. J. Psychoactive Drugs 39 (2007), 1–11.
77. Risner, M.E., Intravenous self-administration of phencyclidine and related compounds in the dog. J. Pharmacol. Exp. Ther. 221 (1982), 637–644.
78. Roberts, B.M., Seymour, P.A., Schmidt, C.J., Williams, G.V., Castner, S.A., Amelioration of ketamine-induced working memory deficits by dopamine D1 receptor agonists. Psychopharmacology (Berl) 210 (2010), 407–418.
79. Rome, E.S., It's a rave new world: rave culture and illicit drug use in the young. Cleve. Clin. J. Med. 68 (2001), 541–550.
80. Romeo, B., Choucha, W., Fossati, P., Rotge, J.Y., Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression. Psychiatry Res. 230 (2015), 682–688.
81. Rowland, L.M., Subanesthetic ketamine: how it alters physiology and behavior in humans. Aviat. Space Environ. Med. 76 (2005), 52–58.
82. Rowland, L.M., Bustillo, J.R., Mullins, P.G., Jung, R.E., Lenroot, R., Landgraf, E., Barrow, R., Yeo, R., Lauriello, J., Brooks, W.M., Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. Am. J. Psychiatry 162 (2005), 394–396.
83. Shahani, R., Streutker, C., Dickson, B., Stewart, R.J., Ketamine-associated ulcerative cystitis: a new clinical entity. Urology 69 (2007), 810–812.
84. Shang, Y., Wu, Y., Yao, S., Wang, X., Feng, D., Yang, W., Protective effect of erythropoietin against ketamine-induced apoptosis in cultured rat cortical neurons: involvement of PI3K/Akt and GSK-3 beta pathway. Apoptosis 12 (2007), 2187–2195.
85. Sheehy, K.A., Muller, E.A., Lippold, C., Nouraie, M., Finkel, J.C., Quezado, Z.M., Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: a longitudinal study. BMC Pediatr., 15, 2015, 198.
86. Singh, D., Chawarski, M.C., Schottenfeld, R., Vicknasingam, B., Substance abuse and the HIV situation in Malaysia. J. Food Drug Anal. 21 (2013), S46–S51.
87. Skeldon, S.C., Goldenberg, S.L., Urological complications of illicit drug use. Nat. Rev. Urol. 11 (2014), 169–177.
88. Solé, B., Jiménez, E., Martinez-Aran, A., Vieta, E., Cognition as a target in major depression: new developments. Eur. Neuropsychopharmacol. 25 (2015), 231–247.
89. Stone, J., Kotoula, V., Dietrich, C., De, S.S., Krystal, J.H., Mehta, M.A., Perceptual distortions and delusional thinking following ketamine administration are related to increased pharmacological MRI signal changes in the parietal lobe. J. Psychopharmacol. (Oxf.), 29, 2015.
90. Suzuki, T., Aoki, T., Kato, H., Yamazaki, M., Misawa, M., Effects of the 5-HT 3 receptor antagonist ondansetron on the ketamine- and dizocilpine-induced place preferences in mice. Eur. J. Pharmacol. 385 (1999), 99–102.
91. Tan, S., Lam, W.P., Wai, M.S., Yu, W.H., Yew, D.T., Chronic ketamine administration modulates midbrain dopamine system in mice. PLoS One, 7, 2012, e43947.
92. Tang, J., Liao, Y., He, H., Deng, Q., Zhang, G., Qi, C., Cui, H., Jiao, B., Yang, M., Feng, Z., et al. Sleeping problems in Chinese illicit drug dependent subjects. BMC Psychiatry, 15, 2015, 28.
93. Tang, M., Ching, C.K., Tse, M.L., Ng, C., Lee, C., Chong, Y.K., Wong, W., Mak, T.W., Emerging Drugs of Abuse Surveillance Study Group, Surveillance of emerging drugs of abuse in Hong Kong: validation of an analytical tool. Hong Kong Med. J. 21 (2015), 114–123.
94. Tedesco, V., Ravagnani, C., Bertoglio, D., Chiamulera, C., Acute ketamine-induced neuroplasticity: ribosomal protein S6 phosphorylation expression in drug addiction-related rat brain areas. Neuroreport 24 (2013), 388–393.
95. Thompson, T., Schuster, C.R., Morphine self-Administration, food-Reinforced, and avoidance behaviors in rhesus monkeys. Psychopharmacologia 5 (1964), 87–94.
96. Tzschentke, T.M., Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict. Biol. 12 (2007), 227–462.
97. van der Kam, E.L., de Vry, J., Tzschentke, T.M., Effect of 2-methyl-6-(phenylethynyl) pyridine on intravenous self-administration of ketamine and heroin in the rat. Behav. Pharmacol. 18 (2007), 717–724.
98. van der Kam, E.L., De Vry, J., Tzschentke, T.M., 2-Methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates ketamine and heroin reward as assessed by acquisition, extinction, and reinstatement of conditioned place preference in the rat. Eur. J. Pharmacol. 606 (2009), 94–101.
99. Venâncio, C., Antunes, L., Félix, L., Rodrigues, P., Summavielle, T., Peixoto, F., Chronic ketamine administration impairs mitochondrial complex I in the rat liver. Life Sci. 93 (2013), 464–470.
100. Venniro, M., Mutti, A., Chiamulera, C., Pharmacological and non-pharmacological factors that regulate the acquisition of ketamine self-administration in rats. Psychopharmacology (Berl) 232 (2015), 4505–4514.
101. Vernaleken, I., Klomp, M., Moeller, O., Raptis, M., Nagels, A., Rosch, F., Schaefer, W.M., Cumming, P., Grunder, G., Vulnerability to psychotogenic effects of ketamine is associated with elevated D2/3-receptor availability. Int. J. Neuropsychopharmacol. 16 (2013), 745–754.
102. Wai, M.S., Chan, W.M., Zhang, A.Q., Wu, Y., Yew, D.T., Long-term ketamine and ketamine plus alcohol treatments produced damages in liver and kidney. Hum. Exp. Toxicol. 31 (2012), 877–886.
103. Weeks, J.R., Experimental morphine addiction: method for automatic intravenous injections in unrestrained rats. Science 138 (1962), 143–144.
104. Weiner, A., Vieira, L., Ca Bayer, M., Ketamine abusers presenting to the emergency department: a case series. J. Emerg. Med. 18 (2000), 447–451.
105. Wilkins, L.K., Girard, T.A., Cheyne, J.A., Anomalous bodily-self experiences among recreational ketamine users. Cogn. Neuropsychiatry 17 (2012), 415–430.
106. Winger, G., Hursh, S.R., Casey, K.L., Woods, J.H., Relative reinforcing strength of three N-methyl-D-aspartate antagonists with different onsets of action. J. Pharmacol. Exp. Ther. 301 (2002), 690–697.
107. Wong, A., Benedict, N.J., Armahizer, M.J., Kanegill, S.L., Evaluation of adjunctive ketamine to benzodiazepines for management of alcohol withdrawal syndrome. Qual. Mark. Res. 9 (2015), 181–193.
108. Wu, S., Lai, Y., He, Y., Li, X., Guan, Z., Cai, Z., Lower urinary tract destruction due to ketamine: a report of 4 cases and review of literature. J. Addict. Med. 6 (2012), 85–88.
109. Xu, J.J., Zhang, C., Hu, Q.H., Chu, Z.X., Zhang, J., Li, Y.Z., Lu, L., Wang, Z., Fu, J.H., Chen, X., et al. Recreational drug use and risks of HIV and sexually transmitted infections among Chinese men who have sex with men: mediation through multiple sexual partnerships. BMC Infect. Dis., 14, 2014, 642.
110. Yang, C., Zhou, Z.Q., Gao, Z.Q., Shi, J.Y., Yang, J.J., Acute increases in plasma mammalian target of rapamycin, glycogen synthase kinase-3beta, and eukaryotic elongation factor 2 phosphorylation after ketamine treatment in three depressed patients. Biol. Psychiatry 73 (2013), e35–36.
111. Yek, J., Sundaram, P., Aydin, H., Kuo, T., Ng, L.G., The clinical presentation and diagnosis of ketamine-associated urinary tract dysfunction in Singapore. Singapore Med. J. 56 (2015), 660–665.
112. Yoshizawa, K., Mori, T., Ueno, T., Nishiwaki, M., Shibasaki, M., Shimizu, N., Narita, M., Suzuki, T., Involvement of serotonin receptor mechanisms in the discriminative stimulus effects of ketamine in rats. J. Pharmacol. Sci. 121 (2013), 237–241.
113. Young, A.M., Herling, S., Winger, G.D., Woods, J.H., Comparison of discriminative and reinforcing effects of ketamine and related compounds in the rhesus monkey. NIDA Res. Monogr. 34 (1981), 173–179.
114. Young, A.M., Woods, J.H., Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories. J. Pharmacol. Exp. Ther. 218 (1981), 720–727.
115. Zgaia, A.O., Irimie, A., Sandesc, D., Vlad, C., Lisencu, C., Rogobete, A., Achimas-Cadariu, P., The role of ketamine in the treatment of chronic cancer pain. Clujul Med. 88 (2015), 457–461.
116. Zhu, X., Ping, L., Hao, X., Ke, W., Su, M., Jie, L., Fei, X., Jin, J., Ketamine-mediated alleviation of electroconvulsive shock-induced memory impairment is associated with the regulation of neuroinflammation and soluble amyloid-beta peptide in depressive-like rats. Neurosci. Lett. 599 (2015), 32–37.
117. Zhuo, X., Cang, Y., Yan, H., Bu, J., Shen, B., The prevalence of drugs in motor vehicle accidents and traffic violations in Shanghai and neighboring cities. Accid. Anal. Prev. 42 (2010), 2179–2184.